{"id":374,"date":"2022-12-29T13:41:20","date_gmt":"2022-12-29T18:41:20","guid":{"rendered":"https:\/\/mivado.com\/mgp\/?page_id=374"},"modified":"2025-05-27T15:41:35","modified_gmt":"2025-05-27T19:41:35","slug":"data-integrity","status":"publish","type":"page","link":"https:\/\/mivado.com\/mgp\/solutions\/data-integrity\/","title":{"rendered":"Data Integrity"},"content":{"rendered":"\n

Mastering and controlling GxP data is essential to ensure that data obtained through GxP activities are complete, consistent, and precise, and thus guarantee decision-making by pharmaceutical industries and laboratories, and the competent authorities.<\/p>\n\n\n\n

Data Integrity (DI), according to the US FDA<\/a>, refers to the completeness, consistency, and accuracy of data. Complete, consistent, and accurate data should be attributable, legible, contemporaneously recorded, original or a true copy, and accurate (ALCOA). These characteristics are important to ensuring data integrity and are addressed throughout the cGMP regulations for drugs.<\/p>\n\n\n

\n
\"\"
Data Integrity<\/strong><\/figcaption><\/figure>\n<\/div>\n\n\n

Per MHRA<\/a>, Data integrity is the degree to which data are complete, consistent, accurate, trustworthy, reliable, and that these characteristics of the data are maintained throughout the data life cycle.<\/p>\n\n\n\n

Mivado Global Performance provides complete Data Transformation and Integrity services and solutions to the key DI issues and expects actions to achieve a high degree of DI compliance regarding Regulatory Requirements.<\/p>\n\n\n\n

Data Integrity enablers<\/h3>\n\n\n\n

Our consultants are ready to support implementing the following Data Integrity enablers:<\/p>\n\n\n\n

\n
\n